← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEPHRON · Approved 2026-06-11

Drug application

FDA Application #

ANDA216272

Application type

Abbreviated New Drug Application (Generic)

Brand name

NOREPINEPHRINE BITARTRATE

Generic name

Norepinephrine Bitartrate

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

NEPHRON

First approval

2026-06-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown